Edema Clinical Trial
Official title:
A Phase II Study of Anti-PD-1 (MK-3475) Therapy in Patients With Metastatic Inflammatory Breast Cancer (IBC) or Non-IBC Triple Negative Breast Cancer (TNBC) Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy
This phase II trial studies how well pembrolizumab works in treating patients with stage IV inflammatory breast cancer or triple-negative breast cancer that has spread to other places in the body (metastatic) or has come back (recurrent), and who have achieved clinical response or stable disease to prior chemotherapy. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.
PRIMARY OBJECTIVES: Primary Objective: To assess the efficacy of MK-3475 as a single agent in patients with metastatic IBC or non-IBC TNBC EXPLORATORY OBJECTIVES: 1. To investigate the association between biomarkers in the peripheral blood and tumor tissue, such as PD-L1 expression, with safety and efficacy for IBC or non-IBC TNBC patients treated with MK-3475. 2. To determine the disease control rate of metastatic IBC or non-IBC TNBC patients who have achieved clinical response or stable disease to the systemic therapy. 3. To investigate the association between biomarkers and efficacy by RNA-sequencing of exosomes in blood and tumor for IBC or non-IBC TNBC patients treated with MK-3475. 4. To investigate the 5-year OS for IBC or non-IBC TNBC patients treated with MK-3475 OUTLINE: Patients receive pembrolizumab 200mg IV over approximately 30 minutes on day 1. Cycles repeat every 21 days for 8 cycles and then pembrolizumab 400mg IV every 42 days for total up to 24 months in the absence of disease progression or unacceptable toxicity After completion of study treatment, patients are followed up at approximately 1 and 3 months. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06003205 -
Contributing Factors to Local Bioimpedance Spectroscopy
|
N/A | |
Completed |
NCT02055872 -
Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled Trial
|
Phase 3 | |
Completed |
NCT01172522 -
Topical Treatment of Under Eye Dark Circles and Swelling
|
Phase 2 | |
Completed |
NCT00602615 -
Bioequivalency Study of Torsemide Tablets Under Fed Conditions
|
N/A | |
Completed |
NCT00602303 -
Bioequivalency Study of Torsemide Tablets Under Fasting Conditions
|
N/A | |
Completed |
NCT00115726 -
Trial Assessing the Effect of Preoperative Furosemide on Intraoperative Blood Pressure
|
Phase 4 | |
Completed |
NCT04595448 -
Lymphatic Function in Patients With Secondary Tricuspid Valve Regurgitation
|
||
Recruiting |
NCT06014203 -
Examination of Edema After Arthroscopic Shoulder Surgery
|
||
Completed |
NCT06010394 -
Control of Edema in the Knee in Patients With Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05310019 -
Effect of Electroacupuncture in Patients Submitted Orthognathic Surgery and Mentoplasty
|
N/A | |
Recruiting |
NCT03442166 -
Effectiveness of Light-emitting Diode (LED) Photobiomodulation in the Extraction of Retained Lower Third Molars
|
Phase 2 | |
Withdrawn |
NCT03603990 -
Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular Edema
|
N/A | |
Completed |
NCT06220903 -
The Effect of Complex Decongestive Therapy in Patients With Lymphedema
|
N/A | |
Recruiting |
NCT04927234 -
Foot and Ankle Post-operative Oedema Management Using Geko™
|
N/A | |
Active, not recruiting |
NCT02876107 -
Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer
|
Phase 2 | |
Recruiting |
NCT03704857 -
Different Endodontic Treatment Techniques in Postoperative Symptoms, Apical Repair, Longevity of Rehabilitations, and Oral Health-related Quality of Life
|
N/A | |
Recruiting |
NCT04606030 -
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
|
N/A | |
Completed |
NCT00732719 -
Compression Device Safety Study on Edema
|
Phase 2 | |
Not yet recruiting |
NCT05534308 -
Effect of Intraoperative Taping on the Control of Edema Resulting From Stripping
|
N/A | |
Completed |
NCT04205253 -
Tongue Depressor-related Ischemia-Reperfusion Injury in Tongue
|